| Revenue | DKK -15K | +35% |
| EBITDA | DKK -15K | -35% |
| Net profit | DKK -24K | -25% |
| Total assets | DKK 0 | — |
| Equity | DKK -234K | -11% |
| Employees | — | — |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -8 | -10 | -10 | -11 | -13 | -10 | -11 | -11 | -11 | -15 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -8 | -10 | -10 | -11 | -13 | -10 | -11 | -11 | -11 | -15 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -8 | -10 | -10 | -11 | -13 | -10 | -11 | -11 | -11 | -15 |
| Net financials | 0 | -2 | -2 | 46 | -106 | -6 | -6 | -5 | -8 | -9 |
| Profit before tax | -8 | -12 | -12 | 36 | -119 | -17 | -16 | -16 | -19 | -24 |
| Tax | -0 | -0 | -0 | -0 | -0 | -8 | -0 | -0 | -0 | -0 |
| Net profit | -8 | -12 | -12 | 36 | -119 | -9 | -16 | -16 | -19 | -24 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 100 | 0 | 8 | 34 | 24 | 0 | 0 |
| Equity | -44 | -55 | -68 | -32 | -151 | -159 | -176 | -192 | -211 | -234 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 44 | 55 | 68 | 132 | 151 | 167 | 210 | 216 | 211 | 234 |
| Total debt | 44 | 55 | 68 | 132 | 151 | 167 | 210 | 216 | 211 | 234 |
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2012 | |
PHARMAVIE A/S | Company | 0.0% | 100.0% | 2012 |
| Individual | 50.0% | 50.0% | 2012 |
| Person | Role here | Other companies |
|---|